Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
BJU International
|
April 27, 2011
British association of urological surgeons' suprapubic catheter practice guidelines
Wasim Mahmalji, Shikohe Masood
Urology
|
October 18, 2008
Outcomes of patients with clinical T1 grade 3 urothelial cell bladder carcinoma treated with radical cystectomy
Shikohe Masood, G R Mufti
Hospital Medicine (London, England : 1998)
|
February 8, 2003
Bladder cancer: a current update
Shikohe Masood, Hassan D Wazait, Manit Arya, et al.
The Journal of Urology
|
May 16, 2006
Re: treatment delay and prognosis in invasive bladder cancer
Shikohe Masood, Peter Pietrzak, Chryssanthos Kourief, et al.
BJU International
|
December 22, 2004
The 12-year outcome analysis of an endourethral wallstent for treating benign prostatic hyperplasia
Shikohe Masood, Hooman Djaladat, Chryssanthos Kouriefs, et al.
Central European Journal of Urology
|
November 3, 2021
Is primary ureteroscopy an alternative to emergency stenting in terms of quality and cost?
Mudassir Wani, Javed Burki, Motaz Melhem, et al.
Therapeutic Advances in Urology
|
October 30, 2023
The implications when offering percutaneous nephrostomy for the management of malignant obstructive uropathy secondary to urological malignancy: can we be more selective?
Elizabeth Osinibi, Hong Doan, Alejandro Mercado-Campero, et al.
The Journal of Urology
|
July 4, 2006
Fate of the leftover bladder after supravesical urinary diversion for benign disease
Tajammul Fazili, Tahir R Bhat, Shikohe Masood, et al.
Archivio Italiano Di Urologia, Andrologia : Organo Ufficiale [Di] Societa Italiana Di Ecografia Urologica E Nefrologica
|
July 15, 2014
Painful bladder syndrome/interstitial cystitis: aetiology, evaluation and management
William Rourke, Shahid Aziz Anwer Khan, Kamran Ahmed, et al.
BJU International
|
March 4, 2020
CALIBER: a phase II randomized feasibility trial of chemoablation with mitomycin-C vs surgical management in low-risk non-muscle-invasive bladder cancer
A Hugh Mostafid, Nuria Porta, Joanne Cresswell, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
BJU International
|
April 27, 2011
British association of urological surgeons' suprapubic catheter practice guidelines
Wasim Mahmalji, Shikohe Masood
Urology
|
October 18, 2008
Outcomes of patients with clinical T1 grade 3 urothelial cell bladder carcinoma treated with radical cystectomy
Shikohe Masood, G R Mufti
Hospital Medicine (London, England : 1998)
|
February 8, 2003
Bladder cancer: a current update
Shikohe Masood, Hassan D Wazait, Manit Arya, et al.
The Journal of Urology
|
May 16, 2006
Re: treatment delay and prognosis in invasive bladder cancer
Shikohe Masood, Peter Pietrzak, Chryssanthos Kourief, et al.
BJU International
|
December 22, 2004
The 12-year outcome analysis of an endourethral wallstent for treating benign prostatic hyperplasia
Shikohe Masood, Hooman Djaladat, Chryssanthos Kouriefs, et al.
Central European Journal of Urology
|
November 3, 2021
Is primary ureteroscopy an alternative to emergency stenting in terms of quality and cost?
Mudassir Wani, Javed Burki, Motaz Melhem, et al.
Therapeutic Advances in Urology
|
October 30, 2023
The implications when offering percutaneous nephrostomy for the management of malignant obstructive uropathy secondary to urological malignancy: can we be more selective?
Elizabeth Osinibi, Hong Doan, Alejandro Mercado-Campero, et al.
The Journal of Urology
|
July 4, 2006
Fate of the leftover bladder after supravesical urinary diversion for benign disease
Tajammul Fazili, Tahir R Bhat, Shikohe Masood, et al.
Archivio Italiano Di Urologia, Andrologia : Organo Ufficiale [Di] Societa Italiana Di Ecografia Urologica E Nefrologica
|
July 15, 2014
Painful bladder syndrome/interstitial cystitis: aetiology, evaluation and management
William Rourke, Shahid Aziz Anwer Khan, Kamran Ahmed, et al.
BJU International
|
March 4, 2020
CALIBER: a phase II randomized feasibility trial of chemoablation with mitomycin-C vs surgical management in low-risk non-muscle-invasive bladder cancer
A Hugh Mostafid, Nuria Porta, Joanne Cresswell, et al.
Page
of 1